Dr. Brandon Fong, MD Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 808-433-1887 |
Ms. Maya Antoine, Hospitalist Medicare: Not Enrolled in Medicare Practice Location: 1 Jarrett White Rd, Tripler Army Medical Center, HI 96859 Phone: 888-683-2778 |
News Archive
GlaxoSmithKline Plc, one of the world's largest pharmaceutical companies, has agreed to pay $750 million to settle a U.S. government false-claims lawsuit over the sale of defective drugs. The lawsuit first filed in 2004 by Cheryl D. Eckard, a former global quality assurance manager for the London-based company came to a settlement finally. Eckard, 51, said, "This is not something I wanted to do, but because of patient safety it was necessary." Being the one to bring this to notice she would receive $96 million from the settlement money. She had warned the company earlier but was fired because of her efforts.
Confidential HIV testing should be required for all people in South Africa so those who test positive can begin safeguarding their health immediately, Francois Venter, head of the Southern African HIV Clinicians Society, said at a news conference on Thursday, the Washington Post reports (Timberg, Washington Post, 10/20).
Writing in the journal Nature, 10 scientists from around the world "say the only chance of achieving global prosperity is for all countries to combine poverty and environmental targets," and they ask "[w]orld leaders [to] set six goals around universal clean energy, an end to water and food shortages, thriving lives and livelihoods, and healthy and productive ecosystems," the Guardian reports.
Ventus Medical, a privately-held medical device company focused on improving the lives of patients with sleep-disordered breathing, today announced that the company's PROVENT(R) Sleep Apnea Therapy received the Runners-Up Award in The Wall Street Journal 2009 Technology Innovation Awards, Medical Devices category. The results were published in the September 14, 2009 edition of The Wall Street Journal.
A comprehensive new gene expression study in embryonic stem cells has uncovered a transcription control mechanism that is not only more pervasive than once thought but is also heavily regulated by the cancer-causing gene c-Myc.
› Verified 6 days ago